Nachrichten zur Johnson Matthey PLC Aktie

Johnson & Johnson: Der alte Dampfer liefert ab

Wien (www.aktiencheck.de) - Johnson & Johnson-Aktienanalyse der Raiffeisen Bank International AG (RBI): Raphael Schicho, Analyst der Raiffeisen Bank International AG (RBI),…

United States Pharmaceutical Market Forecast and Company Analysis Report 2025-2033 Featuring F. Hoffmann-La Roche, Novartis, Abbvie, Johnson & Johnson, Merck, Pfizer, BMS, Sanofi, GSK, Takeda

The United States Pharmaceutical Market is projected to reach $979.25 billion by 2033, from $638.86 billion in 2024, at a…

Why Johnson & Johnson (JNJ) is a Top Dividend Stock for Your Portfolio

Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy…

Why Johnson & Johnson Stock Still Has Room To Run

…

Eli Lilly, Pfizer und Johnson & Johnson im Visier der US-Regierung und auch Novo Nordisk hat momentan wenig zu lachen

Das Geschäftsmodell der großen Pharmakonzerne ist nicht nur weitgehend krisensicher, sondern auch enorm lukrativ. Zu verdanken ist dies zu nicht…

What Is Considered a Good Stock Dividend? 2 Healthcare Stocks That Fit the Bill.

Key PointsReliability is one of the most important things about a dividend.Johnson & Johnson is a Dividend King with an…

JNJ Seeks FDA Approval for Oral Psoriasis Drug Icotrokinra

Johnson & Johnson eyes FDA nod to icotrokinra after phase III studies show strong skin clearance and safety in plaque…

Johnson & Johnson (JNJ) is a Top Dividend Stock Right Now: Should You Buy?

Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy…

Spravato sales momentum underscores market potential for psychedelics, atai Life Sciences seen as key beneficiary

Sales of Johnson & Johnson (NYSE:JNJ)’s esketamine nasal spray Spravato grew sequentially in the second quarter, marking a positive sign for…

Johnson & Johnson Aktie: Wachstum bei "Innovative Medicine" dürfte Prognosen übertreffen

San Francisco (www.aktiencheck.de) - Johnson & Johnson-Aktienanalyse von Wells Fargo Advisors: Die Analysten von Wells Fargo haben das Rating "equal-weight" und…

Johnson & Johnson: The Worst Is Baked In

…

Johnson & Johnson Aktie: Morgan Stanley erhöht Kursziel - aber kein Kauf?

Bad Marienberg (www.aktiencheck.de) - Johnson & Johnson: Kursziel steigt auf 176 USD – Analyst bleibt dennoch zurückhaltend Die Investmentbank Morgan Stanley…

Johnson & Johnsons Healthy 3.3%-Yielding Dividend Is a Very Safe Way to Make Passive Income

Key PointsJohnson & Johnson continues to generate plenty of free cash flow to cover its dividend. The healthcare giant also…

Is Johnson & Johnson a Good Dividend Stock to Buy Now? @themotleyfool #stocks $JNJ

…

3 Top Dividend Stocks Yielding More Than 3% That You Shouldnt Hesitate to Buy Right Now

Key PointsExxonMobil has the best dividend growth track record in the oil industry. Johnson & Johnson has increased its dividend…

Johnson & Johnson (JNJ) Q2 2025 Earnings Call Transcript

…

Johnson & Johnson (JNJ) Q2 Earnings and Revenues Top Estimates

Johnson & Johnson (JNJ) delivered earnings and revenue surprises of +4.14% and +4.13%, respectively, for the quarter ended June 2025.…

Johnson & Johnson (JNJ) Surpasses Q2 Earnings and Revenue Estimates

Johnson & Johnson (JNJ) delivered earnings and revenue surprises of +4.14% and +4.13%, respectively, for the quarter ended June 2025.…

Why Johnson & Johnson Rallied Today

Key PointsJohnson & Johnson delivered a "beat and raise" quarter. Results were bolstered by the new acquisition of Intra-Cellular, marking…

Dows 110-point rally highlighted by gains in Johnson & Johnson, Amgen shares

The Dow Jones Industrial Average is up Wednesday afternoon with shares of Johnson & Johnson and Amgen seeing positive momentum…

Stocks making the biggest moves midday: Morgan Stanley, ASML, Johnson & Johnson, SolarEdge and more

These are the stocks posting the largest moves in midday trading.…

Johnson & Johnson (JNJ) Q2 2025 Earnings Call Transcript

Image source: The Motley Fool. DATEWednesday, July 16, 2025 at 8:30 a.m. ETCALL PARTICIPANTSChairman and Chief Executive Officer — Joaquin DuatoChief…

Wall Street: Nvidia und Johnson & Johnson stehen zum Auftakt im Fokus

Die US-Börsen zeigen sich am Mittwoch uneinheitlich: Während der Dow Jones oder 0,3 Prozent zulegt und der S&P 500 um…

Wall Street: Nvidia und Johnson & Johnson stehen zum Auftakt im Fokus

Die US-Börsen zeigen sich am Mittwoch uneinheitlich: Während der Dow Jones oder 0,3 Prozent zulegt und der S&P 500 um…

Market movers: Johnson & Johnson, Morgan Stanley, Bit Digital...

…

Johnson & Johnson (JNJ) Reports Q2 Earnings: What Key Metrics Have to Say

The headline numbers for Johnson & Johnson (JNJ) give insight into how the company performed in the quarter ended June…

Johnson & Johnson Aktie: Zölle wohl doch nicht so schlimm

Wien (www.aktiencheck.de) - Johnson & Johnson-Aktienanalyse von der Raiffeisen Bank International AG: Raphael Schicho, Analyst der Raiffeisen Bank International AG (RBI),…

Geschäfte mit Medizintechnik treibt Johnson & Johnson an - Prognosen angehoben

NEW BRUNSWICK (dpa-AFX) - Der US-Konzern Johnson & Johnson (J&J) blickt nach einem überraschend guten zweiten Quartal zuversichtlicher auf das…

Stocks making the biggest moves premarket: Goldman Sachs, ASML, Diageo, Johnson & Johnson and more

These are the stocks posting the largest moves in premarket trading.…

Johnson & Johnson beats profit estimates on strong Darzalex, medtech sales

Johnson & Johnson reported second-quarter profit and raised its full-year sales forecast by around $2 billion on Wednesday as strong…

Johnson & Johnson delivers earnings beat, raises full year sales and profit guidance

Johnson & Johnson (NYSE:JNJ) shares edged higher premarket as the healthcare firm reported an earnings beat for the second quarter…

Want to Generate at Least $1,000 in Passive Income Per Year? Invest $26,000 in This Dividend King Stock.

Key PointsKenvue is spending big to drum up demand for its diversified product portfolio.The companys weak results reflect pressure on…

Should You Buy Johnson & Johnson Stock Before July 16th?

Key PointsJohnson & Johnson reports earnings on Wednesday.Investors may be paying attention to tariff-related developments more so than the companys…

Andrew Hill Dumps 38,000 Johnson & Johnson Shares in Q2 2025 Exit

Key PointsThe investment advisor sold 38,037 shares for a total of $6.31 million in Q2 2025.Move removes JNJ from portfolio,…

This Stock Has Increased 4,720%: Heres Why Its Still a Buy

Key PointsJohnson & Johnson has delivered excellent returns to its long-term shareholders. One key factor behind the companys success is…

Johnson & Johnson (JNJ) Expected to Beat Earnings Estimates: Should You Buy?

Johnson & Johnson (JNJ) possesses the right combination of the two key ingredients for a likely earnings beat in its…

Heres Why Johnson & Johnson (JNJ) is a Strong Momentum Stock

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Heres why…

Should You Forget Johnson & Johnson and Buy This Magnificent High-Yield Dividend Stock Instead?

Key PointsJohnson & Johnson is a Dividend King.The stock offers an attractive 3.4% dividend yield.Another healthcare stock has a 7.4%…

Why Johnson & Johnson (JNJ) Could Beat Earnings Estimates Again

Johnson & Johnson (JNJ) has an impressive earnings surprise history and currently possesses the right combination of the two key…

Johnson & Johnson (JNJ) Could Be a Great Choice

Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy…

Is Most-Watched Stock Johnson & Johnson (JNJ) Worth Betting on Now?

Zacks.com users have recently been watching Johnson & Johnson (JNJ) quite a bit. Thus, it is worth knowing the facts…

Top Analyst Reports for Johnson & Johnson, Home Depot and Micron

MU gains 42.5% YTD as AI demand fuels DRAM growth, while JNJ and HD navigate pricing, pipeline, and macro headwinds.…

Johnson & Johnson (JNJ) Rises As Market Takes a Dip: Key Facts

Johnson & Johnson (JNJ) concluded the recent trading session at $155.92, signifying a +2.08% move from its prior days close.…

Johnson & Johnson: Undervalued Dividend King With 65% Upside Potential

…

Zacks Investment Ideas feature highlights: Jabil, Apple, Amazon, Johnson & Johnson and Ericsson

Detailed price information for Jabil Circuit (JBL-N) from The Globe and Mail including charting and trades.…